Peripheral transcutaneous neuromodulation of the post-tibial nerve
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Peripheral transcutaneous neuromodulation of the post-tibial nerve, covering 2018-08-02 to 2018-08-02. Get the full timeline:
Most recent: Clinical Trial Update: Peripheral Transcutaneous Neuromodulation of the Post-tibial Nerve for Solifenacin 10 mg. Hyperactive Bladder Syndrome [Phase 4]